Transcriptional Regulation of Hepatic Stellate Cell Activation by siRNA for TGF-beta1
Korean Journal of Pathology
;
: 503-508, 2009.
Article
in Korean
| WPRIM
| ID: wpr-55852
ABSTRACT
BACKGROUND:
The cytokine-induced activation of hepatic stellate cells (HSC) plays a major role in liver fibrosis. Quiescent HSCs undergo phenotypic transformation called "transdifferentiation" in response to viral, chemical or immune insults to the liver. The cytokine TGF-beta1 plays a key role in progressive liver fibrosis. Since small interfering RNA (siRNA) is a powerful tool for silencing gene expression post-transcriptionally, the present study aimed to determine whether synthetic TGF-beta1 siRNA down-regulates the expression of the TGF-beta1 gene in immortalized and activated rat HSCs (HSC-T6s). The study examined whether synthetic TGF-beta1 siRNA prevents rat HSCs activation and extracellular matrix (ECM) production.METHODS:
TGF-beta1 siRNA or a control (pU6) siRNA was added to HSC-T6 culture media. We then performed RT-PCR and western blot analyses for TGF-beta1 and ECM components (fibronectin, type-I collagen, and TIMP-1).RESULTS:
TGF-beta1 siRNA significantly down-regulated expression of TGF-beta1 mRNA and protein and attenuated mRNA and protein expressions of type-I collagen, fibronectin, and TIMP-1, as compared to the control.CONCLUSIONS:
TGF-beta1 siRNA can effectively down-regulate the expression of TGF-beta1 in rat HSC, resulting in significant inhibition of HSC activation and of ECM production. These data indicate that synthetic TGF-beta1 siRNA can be a useful treatment modality to prevent liver fibrosis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
RNA, Messenger
/
Gene Expression
/
Blotting, Western
/
Collagen
/
Fibronectins
/
Tissue Inhibitor of Metalloproteinase-1
/
Culture Media
/
RNA, Small Interfering
/
Extracellular Matrix
/
Transforming Growth Factor beta1
Limits:
Animals
Language:
Korean
Journal:
Korean Journal of Pathology
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS